Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline Review, H2 2019

“Global Markets Direct’s, ‘Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline Review, H2 2019’, provides an overview of the Ankylosing Spondylitis (Bekhterev’s Disease) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ankylosing Spondylitis (Bekhterev’s Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Ankylosing Spondylitis (Bekhterev’s Disease) and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.”

Scope


– The report provides a snapshot of the global therapeutic landscape of Ankylosing Spondylitis (Bekhterev’s Disease)

– The report reviews pipeline therapeutics for Ankylosing Spondylitis (Bekhterev’s Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources

– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

– The report reviews key players involved Ankylosing Spondylitis (Bekhterev’s Disease) therapeutics and enlists all their major and minor projects

– The report assesses Ankylosing Spondylitis (Bekhterev’s Disease) therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

– The report summarizes all the dormant and discontinued pipeline projects

– The report reviews latest news related to pipeline therapeutics for Ankylosing Spondylitis (Bekhterev’s Disease)”

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of therapeutics under development for Ankylosing Spondylitis (Bekhterev's Disease)

- Identify potential new clients or partners in the target demographic

- Develop strategic initiatives by understanding the focus areas of leading companies

- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

- Devise corrective measures for pipeline projects by understanding Ankylosing Spondylitis (Bekhterev's Disease) pipeline depth and focus of Indication therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Companies mentioned

“AbbVie Inc

Alvotech ehf

Amgen Inc

Beijing Eastern Biotech Co Ltd

Bio-Thera Solutions Ltd

Biocad

Biocon Ltd

BioXpress Therapeutics SA

Clover Biopharmaceuticals

DNX Biopharmaceuticals Inc

FunPep Co Ltd

Galapagos NV

Hengenix Biotech Inc

Huabo Biopharm Co Ltd

Hualan Biological Engineering Inc

Immunwork Inc

Innovent Biologics Inc

InSight Biopharmaceuticals Ltd

Izana Bioscience Ltd

JiangSu Qyuns Therapeutics Co Ltd

Lupin Ltd

Mycenax Biotech Inc

NeuClone Pty Ltd

Nichi-Iko Pharmaceutical Co Ltd

Nimbus Therapeutics LLC

Novartis AG

Pfizer Inc

Pharmapraxis

RNAx Ltd

Shandong Boan Biological Technology Co Ltd

Shandong Danhong Pharmaceutical Co Ltd

Shanghai Junshi Bioscience Co Ltd

Siam Bioscience Co Ltd

Sichuan Haisco Pharmaceutical Co Ltd

Sino Biopharmaceutical Ltd

Sun Pharma Advanced Research Company Ltd

UCB SA

Wuhan Institute of Biological Products Co Ltd

Xbrane Biopharma AB”

Table of Contents

Table of Contents

Table of Contents 2

Introduction 5

Ankylosing Spondylitis (Bekhterev's Disease) - Overview 6

Ankylosing Spondylitis (Bekhterev's Disease) - Therapeutics Development 7

Ankylosing Spondylitis (Bekhterev's Disease) - Therapeutics Assessment 14

Ankylosing Spondylitis (Bekhterev's Disease) - Companies Involved in Therapeutics Development 22

Ankylosing Spondylitis (Bekhterev's Disease) - Drug Profiles 36

Ankylosing Spondylitis (Bekhterev's Disease) - Dormant Projects 182

Ankylosing Spondylitis (Bekhterev's Disease) - Discontinued Products 184

Ankylosing Spondylitis (Bekhterev's Disease) - Product Development Milestones 185

Appendix 195

List of Tables

“List of Tables

Number of Products under Development for Ankylosing Spondylitis (Bekhterev’s Disease), H2 2019

Number of Products under Development by Companies, H2 2019

Number of Products under Development by Companies, H2 2019 (Contd..1), H2 2019

Products under Development by Companies, H2 2019

Products under Development by Companies, H2 2019 (Contd..1), H2 2019

Products under Development by Companies, H2 2019 (Contd..2), H2 2019

Number of Products by Stage and Target, H2 2019

Number of Products by Stage and Mechanism of Action, H2 2019

Number of Products by Stage and Route of Administration, H2 2019

Number of Products by Stage and Molecule Type, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by AbbVie Inc, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by Alvotech ehf, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by Amgen Inc, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by Beijing Eastern Biotech Co Ltd, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by Bio-Thera Solutions Ltd, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by Biocad, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by Biocon Ltd, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by BioXpress Therapeutics SA, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by Clover Biopharmaceuticals, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by DNX Biopharmaceuticals Inc, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by FunPep Co Ltd, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by Galapagos NV, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by Hengenix Biotech Inc, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by Huabo Biopharm Co Ltd, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by Hualan Biological Engineering Inc, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by Immunwork Inc, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by Innovent Biologics Inc, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by InSight Biopharmaceuticals Ltd, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by Izana Bioscience Ltd, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by JiangSu Qyuns Therapeutics Co Ltd, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by Lupin Ltd, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by Mycenax Biotech Inc, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by NeuClone Pty Ltd, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by Nichi-Iko Pharmaceutical Co Ltd, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by Nimbus Therapeutics LLC, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by Novartis AG, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by Pfizer Inc, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by Pharmapraxis, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by RNAx Ltd, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by Shandong Boan Biological Technology Co Ltd, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by Shandong Danhong Pharmaceutical Co Ltd, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by Shanghai Junshi Bioscience Co Ltd, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by Siam Bioscience Co Ltd, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by Sichuan Haisco Pharmaceutical Co Ltd, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by Sino Biopharmaceutical Ltd, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by Sun Pharma Advanced Research Company Ltd, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by UCB SA, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by Wuhan Institute of Biological Products Co Ltd, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Pipeline by Xbrane Biopharma AB, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Dormant Projects, H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Dormant Projects, H2 2019 (Contd..1), H2 2019

Ankylosing Spondylitis (Bekhterev’s Disease) – Discontinued Products, H2 2019”

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports